+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Lateral Flow Assays Market Research Report by Product, Technique, Sample Type, Application, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 134 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5470767
UP TO OFF until Dec 31st 2022
The United States Lateral Flow Assays Market size was estimated at USD 1,231.41 million in 2021, USD 1,282.00 million in 2022, and is projected to grow at a CAGR of 5.93% to reach USD 1,740.65 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Lateral Flow Assays to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Kits & Reagents and Lateral Flow Readers. The Lateral Flow Readers is further studied across Benchtop Readers, Digital/Handheld Readers, and Mobile/Smartphone Readers.
  • Based on Technique, the market was studied across Competitive Assays, Multiplex Detection Assays, and Sandwich Assays.
  • Based on Sample Type, the market was studied across Blood Samples, Saliva Samples, and Urine Samples.
  • Based on Application, the market was studied across Clinical Testing, Drug Development & Quality Testing, Food Safety & Environment Testing, and Veterinary Diagnostics. The Clinical Testing is further studied across Cardiac Marker Testing, Cholesterol Testing/Lipid Profiles, Drugs-of-Abuse Testing, Infectious Disease Testing, and Pregnancy & Fertility Testing. The Cardiac Marker Testing is further studied across BNP or NT-proBNP Testing, CK-MB Testing, D-Dimer Testing, Myoglobin Testing, Other Cardiac Markers, and Troponin I & T Testing. The Infectious Disease Testing is further studied across Covid-19, Hepatitis, Influenza, Mosquito-borne Diseases, Sexually Transmitted Infections, and Tuberculosis. The Sexually Transmitted Infections is further studied across Chlamydia, Gonorrhea, HIV, HPV, and Syphilis. The Pregnancy & Fertility Testing is further studied across Fertility Testing and Pregnancy Testing.
  • Based on End-User, the market was studied across Diagnostic Laboratories, Home Care Settings, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Lateral Flow Assays market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Lateral Flow Assays Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Lateral Flow Assays Market, including Abbott Laboratories, Inc., Abcam plc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, BioPorto Diagnostics A/S, Chembio Diagnostic Systems, Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., Hologic Inc., Merck KGaA, Microcoat Biotechnologie GmbH, OraSure Technologies, Inc., PerkinElmer Inc., Polysciences, Inc., QIAGEN N.V, Quidel Corporation, Siemens AG, Surmodics IVD, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Lateral Flow Assays Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Lateral Flow Assays Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Lateral Flow Assays Market?
4. What is the competitive strategic window for opportunities in the United States Lateral Flow Assays Market?
5. What are the technology trends and regulatory frameworks in the United States Lateral Flow Assays Market?
6. What is the market share of the leading vendors in the United States Lateral Flow Assays Market?
7. What modes and strategic moves are considered suitable for entering the United States Lateral Flow Assays Market?
Frequently Asked Questions about the U.S. Lateral Flow Assays Market

What is the estimated value of the U.S. Lateral Flow Assays Market?

The U.S. Lateral Flow Assays Market was estimated to be valued at $1231.41 Million in 2021.

What is the growth rate of the U.S. Lateral Flow Assays Market?

The growth rate of the U.S. Lateral Flow Assays Market is 5.9%, with an estimated value of $1740.65 Million by 2027.

What is the forecasted size of the U.S. Lateral Flow Assays Market?

The U.S. Lateral Flow Assays Market is estimated to be worth $1740.65 Million by 2027.

Who are the key companies in the U.S. Lateral Flow Assays Market?

Key companies in the U.S. Lateral Flow Assays Market include Abbott Laboratories, Inc., Abcam plc, Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., bioMérieux SA, BioPorto Diagnostics A/S, Chembio Diagnostic Systems, Inc. and F. Hoffman.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapidly increasing demand for point-of-care testing
5.1.1.2. High prevalence of infectious diseases across the United States
5.1.2. Restraints
5.1.2.1. Reluctance towards changing existing diagnostic practices
5.1.3. Opportunities
5.1.3.1. Rapid funding and investments in research and innovation in the lateral flow assays
5.1.3.2. Presence of several large hospitals and healthcare systems in the U.S.
5.1.4. Challenges
5.1.4.1. Difficulties in procuring quality raw materials for the development of lateral flow assay tests
5.2. Cumulative Impact of COVID-19
6. Lateral Flow Assays Market, by Product
6.1. Introduction
6.2. Kits & Reagents
6.3. Lateral Flow Readers
6.4.1. Benchtop Readers
6.4.2. Digital/Handheld Readers
6.4.3. Mobile/Smartphone Readers
7. Lateral Flow Assays Market, by Technique
7.1. Introduction
7.2. Competitive Assays
7.3. Multiplex Detection Assays
7.4. Sandwich Assays
8. Lateral Flow Assays Market, by Sample Type
8.1. Introduction
8.2. Blood Samples
8.3. Saliva Samples
8.4. Urine Samples
9. Lateral Flow Assays Market, by Application
9.1. Introduction
9.2. Clinical Testing
9.3.1. Cardiac Marker Testing
9.3.2.1. BNP or NT-proBNP Testing
9.3.2.2. CK-MB Testing
9.3.2.3. D-Dimer Testing
9.3.2.4. Myoglobin Testing
9.3.2.5. Other Cardiac Markers
9.3.2.6. Troponin I & T Testing
9.3.2. Cholesterol Testing/Lipid Profiles
9.3.3. Drugs-of-Abuse Testing
9.3.4. Infectious Disease Testing
9.3.5.1. Covid-19
9.3.5.2. Hepatitis
9.3.5.3. Influenza
9.3.5.4. Mosquito-borne Diseases
9.3.5.5. Sexually Transmitted Infections
9.3.5.6.1. Chlamydia
9.3.5.6.2. Gonorrhea
9.3.5.6.3. HIV
9.3.5.6.4. HPV
9.3.5.6.5. Syphilis
9.3.5.6. Tuberculosis
9.3.5. Pregnancy & Fertility Testing
9.3.6.1. Fertility Testing
9.3.6.2. Pregnancy Testing
9.3. Drug Development & Quality Testing
9.4. Food Safety & Environment Testing
9.5. Veterinary Diagnostics
10. Lateral Flow Assays Market, by End-User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care Settings
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. California Lateral Flow Assays Market
11.1. Introduction
12. Florida Lateral Flow Assays Market
12.1. Introduction
13. Illinois Lateral Flow Assays Market
13.1. Introduction
14. New York Lateral Flow Assays Market
14.1. Introduction
15. Ohio Lateral Flow Assays Market
15.1. Introduction
16. Pennsylvania Lateral Flow Assays Market
16.1. Introduction
17. Texas Lateral Flow Assays Market
17.1. Introduction
18. Competitive Landscape
18.1. FPNV Positioning Matrix
18.1.1. Quadrants
18.1.2. Business Strategy
18.1.3. Product Satisfaction
18.2. Market Ranking Analysis, By Key Player
18.3. Market Share Analysis, By Key Player
18.4. Competitive Scenario
18.4.1. Merger & Acquisition
18.4.2. Agreement, Collaboration, & Partnership
18.4.3. New Product Launch & Enhancement
18.4.4. Investment & Funding
18.4.5. Award, Recognition, & Expansion
19. Company Usability Profiles
19.1. Abbott Laboratories, Inc.
19.1.1. Business Overview
19.1.2. Key Executives
19.1.3. Product & Services
19.2. Abcam plc
19.2.1. Business Overview
19.2.2. Key Executives
19.2.3. Product & Services
19.3. Becton, Dickinson and Company
19.3.1. Business Overview
19.3.2. Key Executives
19.3.3. Product & Services
19.4. Bio-Rad Laboratories, Inc.
19.4.1. Business Overview
19.4.2. Key Executives
19.4.3. Product & Services
19.5. bioMérieux SA
19.5.1. Business Overview
19.5.2. Key Executives
19.5.3. Product & Services
19.6. BioPorto Diagnostics A/S
19.6.1. Business Overview
19.6.2. Key Executives
19.6.3. Product & Services
19.7. Chembio Diagnostic Systems, Inc.
19.7.1. Business Overview
19.7.2. Key Executives
19.7.3. Product & Services
19.8. Danaher Corporation
19.8.1. Business Overview
19.8.2. Key Executives
19.8.3. Product & Services
19.9. F. Hoffman-La Roche Ltd.
19.9.1. Business Overview
19.9.2. Key Executives
19.9.3. Product & Services
19.10. Hologic Inc.
19.10.1. Business Overview
19.10.2. Key Executives
19.10.3. Product & Services
19.11. Merck KGaA
19.11.1. Business Overview
19.11.2. Key Executives
19.11.3. Product & Services
19.12. Microcoat Biotechnologie GmbH
19.12.1. Business Overview
19.12.2. Key Executives
19.12.3. Product & Services
19.13. OraSure Technologies, Inc.
19.13.1. Business Overview
19.13.2. Key Executives
19.13.3. Product & Services
19.14. PerkinElmer Inc.
19.14.1. Business Overview
19.14.2. Key Executives
19.14.3. Product & Services
19.15. Polysciences, Inc.
19.15.1. Business Overview
19.15.2. Key Executives
19.15.3. Product & Services
19.16. QIAGEN N.V
19.16.1. Business Overview
19.16.2. Key Executives
19.16.3. Product & Services
19.17. Quidel Corporation
19.17.1. Business Overview
19.17.2. Key Executives
19.17.3. Product & Services
19.18. Siemens AG
19.18.1. Business Overview
19.18.2. Key Executives
19.18.3. Product & Services
19.19. Surmodics IVD
19.19.1. Business Overview
19.19.2. Key Executives
19.19.3. Product & Services
19.20. Thermo Fisher Scientific, Inc.
19.20.1. Business Overview
19.20.2. Key Executives
19.20.3. Product & Services
20. Appendix
20.1. Discussion Guide
20.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES LATERAL FLOW ASSAYS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES LATERAL FLOW ASSAYS MARKET DYNAMICS
FIGURE 8. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 11. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY KITS & REAGENTS, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY LATERAL FLOW READERS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BENCHTOP READERS, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIGITAL/HANDHELD READERS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOBILE/SMARTPHONE READERS, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (%)
FIGURE 17. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNIQUE, 2027
FIGURE 19. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX DETECTION ASSAYS, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2021 VS 2027 (%)
FIGURE 23. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY SAMPLE TYPE, 2027
FIGURE 25. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BLOOD SAMPLES, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA SAMPLES, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY URINE SAMPLES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 29. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 31. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL TESTING, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BNP OR NT-PROBNP TESTING, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CK-MB TESTING, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY D-DIMER TESTING, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MYOGLOBIN TESTING, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY OTHER CARDIAC MARKERS, 2018-2027 (USD MILLION)
FIGURE 38. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TROPONIN I & T TESTING, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHOLESTEROL TESTING/LIPID PROFILES, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUGS-OF-ABUSE TESTING, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COVID-19, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFLUENZA, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOSQUITO-BORNE DISEASES, 2018-2027 (USD MILLION)
FIGURE 46. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2027 (USD MILLION)
FIGURE 47. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHLAMYDIA, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY GONORRHEA, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HIV, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HPV, 2018-2027 (USD MILLION)
FIGURE 51. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SYPHILIS, 2018-2027 (USD MILLION)
FIGURE 52. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD MILLION)
FIGURE 53. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2027 (USD MILLION)
FIGURE 54. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FERTILITY TESTING, 2018-2027 (USD MILLION)
FIGURE 55. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY TESTING, 2018-2027 (USD MILLION)
FIGURE 56. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG DEVELOPMENT & QUALITY TESTING, 2018-2027 (USD MILLION)
FIGURE 57. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY & ENVIRONMENT TESTING, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 59. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 60. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 61. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 62. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2027 (USD MILLION)
FIGURE 63. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2027 (USD MILLION)
FIGURE 64. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
FIGURE 65. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 66. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. OHIO LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. UNITED STATES LATERAL FLOW ASSAYS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 74. UNITED STATES LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 75. UNITED STATES LATERAL FLOW ASSAYS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES LATERAL FLOW ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY KITS & REAGENTS, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY LATERAL FLOW READERS, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY LATERAL FLOW READERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BENCHTOP READERS, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BENCHTOP READERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIGITAL/HANDHELD READERS, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIGITAL/HANDHELD READERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOBILE/SMARTPHONE READERS, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOBILE/SMARTPHONE READERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COMPETITIVE ASSAYS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX DETECTION ASSAYS, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MULTIPLEX DETECTION ASSAYS, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SANDWICH ASSAYS, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BLOOD SAMPLES, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BLOOD SAMPLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA SAMPLES, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA SAMPLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY URINE SAMPLES, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY URINE SAMPLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL TESTING, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BNP OR NT-PROBNP TESTING, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY BNP OR NT-PROBNP TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CK-MB TESTING, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CK-MB TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY D-DIMER TESTING, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY D-DIMER TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MYOGLOBIN TESTING, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MYOGLOBIN TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY OTHER CARDIAC MARKERS, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY OTHER CARDIAC MARKERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 45. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TROPONIN I & T TESTING, 2018-2027 (USD MILLION)
TABLE 46. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TROPONIN I & T TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 47. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHOLESTEROL TESTING/LIPID PROFILES, 2018-2027 (USD MILLION)
TABLE 48. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHOLESTEROL TESTING/LIPID PROFILES, BY STATE, 2018-2027 (USD MILLION)
TABLE 49. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUGS-OF-ABUSE TESTING, 2018-2027 (USD MILLION)
TABLE 50. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUGS-OF-ABUSE TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 51. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2027 (USD MILLION)
TABLE 52. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 53. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COVID-19, 2018-2027 (USD MILLION)
TABLE 54. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY COVID-19, BY STATE, 2018-2027 (USD MILLION)
TABLE 55. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
TABLE 56. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HEPATITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFLUENZA, 2018-2027 (USD MILLION)
TABLE 58. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFLUENZA, BY STATE, 2018-2027 (USD MILLION)
TABLE 59. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOSQUITO-BORNE DISEASES, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MOSQUITO-BORNE DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 61. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 63. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHLAMYDIA, 2018-2027 (USD MILLION)
TABLE 64. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY CHLAMYDIA, BY STATE, 2018-2027 (USD MILLION)
TABLE 65. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY GONORRHEA, 2018-2027 (USD MILLION)
TABLE 66. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY GONORRHEA, BY STATE, 2018-2027 (USD MILLION)
TABLE 67. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HIV, 2018-2027 (USD MILLION)
TABLE 68. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HIV, BY STATE, 2018-2027 (USD MILLION)
TABLE 69. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HPV, 2018-2027 (USD MILLION)
TABLE 70. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HPV, BY STATE, 2018-2027 (USD MILLION)
TABLE 71. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SYPHILIS, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SYPHILIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TUBERCULOSIS, 2018-2027 (USD MILLION)
TABLE 74. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY TUBERCULOSIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 75. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2027 (USD MILLION)
TABLE 76. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 77. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FERTILITY TESTING, 2018-2027 (USD MILLION)
TABLE 78. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FERTILITY TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 79. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY TESTING, 2018-2027 (USD MILLION)
TABLE 80. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 81. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG DEVELOPMENT & QUALITY TESTING, 2018-2027 (USD MILLION)
TABLE 82. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DRUG DEVELOPMENT & QUALITY TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 83. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY & ENVIRONMENT TESTING, 2018-2027 (USD MILLION)
TABLE 84. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY & ENVIRONMENT TESTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 85. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY DIAGNOSTICS, 2018-2027 (USD MILLION)
TABLE 86. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 87. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 88. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2027 (USD MILLION)
TABLE 89. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 90. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2027 (USD MILLION)
TABLE 91. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 92. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
TABLE 93. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 94. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
TABLE 95. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 96. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 97. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 98. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 99. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 100. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 101. CALIFORNIA LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 102. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 104. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 105. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 106. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 107. FLORIDA LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 108. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 110. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 111. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 112. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 113. ILLINOIS LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 114. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 116. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 117. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 118. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 119. NEW YORK LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 120. OHIO LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. OHIO LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 122. OHIO LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 123. OHIO LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 124. OHIO LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 125. OHIO LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 126. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 128. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 129. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 130. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 131. PENNSYLVANIA LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 132. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 134. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, BY TECHNIQUE, 2018-2027 (USD MILLION)
TABLE 135. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2027 (USD MILLION)
TABLE 136. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 137. TEXAS LATERAL FLOW ASSAYS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 138. UNITED STATES LATERAL FLOW ASSAYS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 139. UNITED STATES LATERAL FLOW ASSAYS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 140. UNITED STATES LATERAL FLOW ASSAYS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 141. UNITED STATES LATERAL FLOW ASSAYS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 142. UNITED STATES LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 143. UNITED STATES LATERAL FLOW ASSAYS MARKET MERGER & ACQUISITION
TABLE 144. UNITED STATES LATERAL FLOW ASSAYS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 145. UNITED STATES LATERAL FLOW ASSAYS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 146. UNITED STATES LATERAL FLOW ASSAYS MARKET INVESTMENT & FUNDING
TABLE 147. UNITED STATES LATERAL FLOW ASSAYS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 148. UNITED STATES LATERAL FLOW ASSAYS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Abcam plc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • BioPorto Diagnostics A/S
  • Chembio Diagnostic Systems, Inc.
  • Danaher Corporation
  • F. Hoffman-La Roche Ltd.
  • Hologic Inc.
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • OraSure Technologies, Inc.
  • PerkinElmer Inc.
  • Polysciences, Inc.
  • QIAGEN N.V
  • Quidel Corporation
  • Siemens AG
  • Surmodics IVD
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...